companydata.dkcompanydata.dk

Tandlægeselskabet Colosseum Brøndby ApS: Financial statements 2024

CVR: 37362085

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Tandlægeselskabet Colosseum Brøndby ApS (CVR 37362085) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 36,740,888 and a net result of DKK 1,492,484 compared with DKK 3,290,499 the year before. That is an increase of 11.6% compared with the year before. Equity in the 2024 report amounted to DKK 12,865,092. The solvency ratio was 59.7%. The company had 35 employees in the financial year.

Gross Profit
DKK 36,740,888
Profit/Loss
DKK 1,492,484
Equity
DKK 12,865,092
Total Assets
DKK 21,538,131
Employees
35

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-36.7M1.5M12.9M35
2023-32.9M3.3M11.4M35
2022-28.5M-2M8.1M35
2021-24.3M-3.6M10M36
2020-20.4M-2.4M13.6M30

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Tandlægeselskabet Colosseum Brøndby ApS: The 2023 annual report is outJul 9, 2024

Tandlægeselskabet Colosseum Brøndby ApS has published its annual report for 2023. Gross profit came to DKK 32,914,030, and the net result was DKK 3,290,499.

Åsa Inger Helena Blom joins Tandlægeselskabet Colosseum Brøndby ApS as directorJul 1, 2024

As of July 1, 2024, Åsa Inger Helena Blom is registered as director of Tandlægeselskabet Colosseum Brøndby ApS.

About Tandlægeselskabet Colosseum Brøndby ApS

Tandlægeselskabet Colosseum Brøndby ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2015. The company is registered under the industry Tandlægers aktiviteter. The company was previously named Colosseum Brøndby ApS and Tandlægeselskabet Evident ApS. The management consists of Erik Andersen. The board consists of Pernille Schlütter Beck (chair), Erik Andersen and Mathias Riis Damgaard. The company is owned by Tandlæge Erik Andersen Holding ApS and Evident Holding ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 38,824,010 and a net result of DKK 477,969 compared with DKK 1,492,484 the year before. Equity in the 2025 report amounted to DKK 13,099,871.

Source: annual report 2025, Danish Business Authority